Profile of antiretroviral and its outcome on patients with HIV-AIDS in Wamena Public Hospital
Autor: | Stefania Rany Seran, Erwin Astha Triyono, Didik Hasmono |
---|---|
Rok vydání: | 2019 |
Předmět: |
Drug
Pediatrics medicine.medical_specialty business.industry Medical record media_common.quotation_subject antiretroviral virus diseases Retrospective cohort study Dermatology CD4 count lcsh:RL1-803 medicine.disease Regimen Acquired immunodeficiency syndrome (AIDS) Health care Public hospital outcome therapy lcsh:Dermatology medicine HIV/AIDS Observational study hospital business media_common |
Zdroj: | Dermatology Reports, Vol 11, Iss 1s (2019) |
ISSN: | 2036-7406 2036-7392 |
DOI: | 10.4081/dr.2019.8063 |
Popis: | In Papua, HIV/AIDS is characterized as a widespread epidemic, with a prevalence of 2.3% and a case rate of 416.91 per 100.000. The low accessibility of healthcare services is a major challenge for health services in Papua. The purpose of this study was to determine the profile of ARV use and therapy outcomes of HIV/AIDS patients at Wamena Public Hospital in Papua. This research is an observational cross-sectional retrospective study. Data was collected from the medical records of 236 patients who met the inclusion criteria. Study showed that FDC (TDF + 3TC + EFV) is the most frequently used ARV. ARV therapy improved the clinical condition of 14 patients, and 9 patients had a worsening of their clinical condition. There was an increase in CD4 cell count after 6, 12, and 24 months of ARV therapy in 76%; 55%; and 72% of patients. There were 55 adverse drug events that required a change of regimen. Based on this study, the use of antiretroviral drugs improved clinical condition, decreasing the number of IO, and increasing the patient's CD4 cell count. |
Databáze: | OpenAIRE |
Externí odkaz: |